Skip to main content
OpenTrials
Completed

NCT Number: NCT05895279

Assessment of Research Digest Impact for Minority with Prostate Cancer, MiCAP Phase III Study

This phase III trial determines how well the Minority Prostate Cancer (MiCaP) Research Digest works in providing information to black men about the latest prostate cancer research. MiCaP Research Digest may be an effective method to help people learn about prostate cancer.This goal of this trial is to create educational programming that helps Black men make informed decisions about their prostate healthcare since Black men are diagnosed with prostate cancer more than any other race or ethnicity.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Prostate Carcinoma Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Male Urogenital Diseases Neoplasms Neoplasms by Site Prostatic Diseases Prostatic Neoplasms Urogenital Diseases Urogenital Neoplasms

Age range

35 year–70 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Mayo Clinic in Florida

Jacksonville, Florida, 32224-9980, United States

About this study

PRIMARY OBJECTIVE:

I. To develop a research dissemination program, the Minority Prostate Cancer (MiCaP) Research Digest, which will spread information about CaP scientific discoveries, evidence-based interventions, and open clinical trials instantly among black males (BM).

OUTLINE: Participants are randomized to 1 of 2 arms.

ARM I: Participants watch MiCaP Research Digest video on study. Participants complete a survey throughout the trial.

ARM II: Participants watch an alternative video on study. Participants complete a survey throughout the trial.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Identify as a Black male
  • Between the ages of 35 and 70
  • For virtual data collection, have access to the internet and Zoom (if joining study online)
  • For virtual data collection, reside anywhere in the U.S.
  • For in-person data collection, reside in one of the nine (9) catchment areas of the Mayo Clinic Cancer Center: Baker, Duval, Nassau, Clay, St. John's, Putnam, Flagler, Volusia and Brevard

Exclusion criteria

  • Identify as a race or ethnicity that is not Black
  • Identify as female
  • Be younger than age 35 and older than age 70
  • Lack access to internet and Zoom (if joining study online)

Treatment and study plan

Media Intervention

Other

Watch MiCaP Research Digest video

Survey Administration

Other

Complete survey

Primary outcomes

  1. Change in perception of access to medical services and general health

    Time frame: Baseline, 1 hour after video intervention

    Using the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 10 questions regarding access to medical services and general health with a yes/no response.

  2. Change in perception in participation with clinical trials about prostate cancer

    Time frame: Baseline, 1 hour after video intervention

    Using the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 10 questions regarding views on participating in clinical trials about prostate cancer with a yes/no response.

  3. Change in perception of familiarity with prostate cancer research

    Time frame: Baseline, 1 hour after video intervention

    Using the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 5 questions regarding views on participating in clinical trials about prostate cancer with a true/false/don't know response.

  4. Change in perception of familiarity with a research study protocol

    Time frame: Baseline, 1 hour after video intervention

    Using the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 5 questions regarding information about a study protocol with a true/false/don't know response.

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

Minority Prostate Cancer (MiCaP) Phase III (Aim 3): Assessment of Research Digest Impact

Acronym: MiCaP

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Jun 8, 2023
Registry last updated
Nov 4, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.